• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症的长期生存:一项基于人群的研究。

Long-term survival in amyotrophic lateral sclerosis: a population-based study.

机构信息

Department of Neurosciences, IRCSS, Mario Negri Institute of Pharmacological Research, Milan.

出版信息

Ann Neurol. 2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24.

DOI:10.1002/ana.24096
PMID:24382602
Abstract

OBJECTIVE

To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify predictors of prolonged survival in a population-based cohort of newly diagnosed patients.

METHODS

An incident cohort from a population-based registry during the years 1998 through 2002 in Lombardy, Italy was followed until death or to February 28, 2013. Age, sex, date of onset of symptoms, site of onset, date of diagnosis, and El Escorial diagnostic category were collected. Survival was assessed using Kaplan-Meier curves. Cox proportional hazards function was used to identify independent prognostic predictors. Standardized mortality ratios (SMRs) were used to assess the 5-year and 10-year excess mortality of ALS patients.

RESULTS

Included were 280 men and 203 women aged 18 to 93 years. Spinal onset ALS was present in 312 cases (64.6%). Definite ALS was diagnosed in 213 cases (44.1%), probable ALS in 130 (26.9%), possible ALS in 93 (19.3%), and suspected ALS in 47 (9.7%). The cumulative time-dependent survival at 1, 5, and 10 years from diagnosis was 76.2%, 23.4%, and 11.8%, respectively. Independent predictors included younger age, the diagnosis of possible/suspected ALS, spinal onset, and symptoms having started >12 months previously at diagnosis. SMR was 9.4 at 5 years and 5.4 at 10 years. SMR at 10 years was higher until age 75 year, predominating in women, and became nonsignificant for males thereafter.

INTERPRETATION

The outcome in ALS varies with phenotype. Longer survival is predicted by younger age, spinal onset, male gender, and suspected ALS. After age 75 years, 10-year survival in men with ALS is similar to the general population.

摘要

目的

确定肌萎缩侧索硬化症(ALS)的长期生存率,并确定新诊断患者人群中延长生存的预测因素。

方法

意大利伦巴第地区一个基于人群的登记处于 1998 年至 2002 年期间收集了一个发病队列,随访至死亡或 2013 年 2 月 28 日。收集了年龄、性别、症状发作日期、发作部位、诊断日期和 El Escorial 诊断类别。使用 Kaplan-Meier 曲线评估生存情况。使用 Cox 比例风险函数确定独立的预后预测因素。使用标准化死亡率比(SMR)评估 ALS 患者的 5 年和 10 年超额死亡率。

结果

纳入了 280 名男性和 203 名年龄在 18 至 93 岁之间的女性。312 例(64.6%)为脊髓发病 ALS。213 例(44.1%)明确诊断为 ALS,130 例(26.9%)可能诊断为 ALS,93 例(19.3%)可疑诊断为 ALS,47 例(9.7%)疑似诊断为 ALS。从诊断起,1、5 和 10 年的累积时间依赖性生存率分别为 76.2%、23.4%和 11.8%。独立预测因素包括年龄较小、可能/疑似 ALS 的诊断、脊髓发病和症状在诊断前 12 个月以上开始。5 年时的 SMR 为 9.4,10 年时为 5.4。10 年 SMR 在 75 岁之前较高,主要见于女性,此后对于男性则不再显著。

解释

ALS 的结局因表型而异。年轻、脊髓发病、男性和疑似 ALS 预测生存率延长。75 岁后,ALS 男性的 10 年生存率与一般人群相似。

相似文献

1
Long-term survival in amyotrophic lateral sclerosis: a population-based study.肌萎缩侧索硬化症的长期生存:一项基于人群的研究。
Ann Neurol. 2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24.
2
Survival of patients with amyotrophic lateral sclerosis in a population-based registry.基于人群登记系统的肌萎缩侧索硬化症患者生存率
Neuroepidemiology. 2005;25(3):114-9. doi: 10.1159/000086353. Epub 2005 Jun 13.
3
Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.肌萎缩侧索硬化症长期生存的预测因素:一项基于人群的研究。
J Neurol Sci. 2008 May 15;268(1-2):28-32. doi: 10.1016/j.jns.2007.10.023. Epub 2007 Nov 19.
4
Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.1966年至2005年日本和歌山县肌萎缩侧索硬化症患者的生存率
J Neurol Sci. 2008 May 15;268(1-2):95-101. doi: 10.1016/j.jns.2007.11.011. Epub 2007 Dec 31.
5
Incidence of ALS in Lombardy, Italy.意大利伦巴第地区肌萎缩侧索硬化症的发病率。
Neurology. 2007 Jan 9;68(2):141-5. doi: 10.1212/01.wnl.0000250339.14392.bb.
6
[Survival in amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的生存情况]
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):19-23.
7
Prognostic categories for amyotrophic lateral sclerosis.肌萎缩侧索硬化症的预后分类。
Amyotroph Lateral Scler. 2012 Oct;13(6):502-8. doi: 10.3109/17482968.2012.679281. Epub 2012 Jun 7.
8
The predictors of survival in Chinese amyotrophic lateral sclerosis patients.中国肌萎缩侧索硬化症患者生存的预测因素。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):237-44. doi: 10.3109/21678421.2014.993650. Epub 2015 Jan 12.
9
Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.利鲁唑与肌萎缩侧索硬化症患者的生存情况:意大利南部的一项基于人群的研究。
Eur J Neurol. 2007 Mar;14(3):262-8. doi: 10.1111/j.1468-1331.2006.01575.x.
10
Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的结局指标和预后指标
Amyotroph Lateral Scler. 2008 Jun;9(3):163-7. doi: 10.1080/17482960801942695.

引用本文的文献

1
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study.探索糖尿病在肌萎缩侧索硬化症中的作用:一项基于人群的队列研究。
Life (Basel). 2025 Jun 10;15(6):936. doi: 10.3390/life15060936.
2
Shape Alterations of Subcortical Nuclei Correlate With Amyotrophic Lateral Sclerosis Progression.皮质下核团的形态改变与肌萎缩侧索硬化症的进展相关。
Brain Behav. 2025 May;15(5):e70495. doi: 10.1002/brb3.70495.
3
Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore.新加坡一个临床队列中肌萎缩侧索硬化症进展和死亡率的预测分析。
Muscle Nerve. 2025 Jul;72(1):71-81. doi: 10.1002/mus.28416. Epub 2025 Apr 23.
4
Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995-2018): Results From the Piemonte and Valle d'Aosta Registry.肌萎缩侧索硬化症患者平均生存期的变化(1995 - 2018年):皮埃蒙特和瓦莱达奥斯塔登记处的结果
Neurology. 2025 Apr 22;104(8):e213467. doi: 10.1212/WNL.0000000000213467. Epub 2025 Mar 24.
5
An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study.肌萎缩侧索硬化症中便秘症状与疾病进展及生存关联的重叠加权分析:一项巢式病例对照研究
Ther Adv Neurol Disord. 2025 Jan 9;18:17562864241309811. doi: 10.1177/17562864241309811. eCollection 2025.
6
Fasciculation potentials are related to the prognosis of amyotrophic lateral sclerosis.肌束震颤电位与肌萎缩侧索硬化症的预后相关。
PLoS One. 2024 Nov 8;19(11):e0313307. doi: 10.1371/journal.pone.0313307. eCollection 2024.
7
Trends in Hospital Admissions for Patients with Amyotrophic Lateral Sclerosis: Insights from a Retrospective Cohort Study in a Province in Northern Italy.肌萎缩侧索硬化症患者的住院趋势:来自意大利北部某省一项回顾性队列研究的见解
Life (Basel). 2024 Jul 27;14(8):941. doi: 10.3390/life14080941.
8
Clinical and Genetic Aspects of Juvenile Amyotrophic Lateral Sclerosis: A Promising Era Emerges.青少年肌萎缩性侧索硬化症的临床与遗传学研究进展:曙光初现。
Genes (Basel). 2024 Feb 28;15(3):311. doi: 10.3390/genes15030311.
9
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology.临床定义的 ALS 分期与脑病理学负担不匹配。
J Neurol. 2024 May;271(5):2547-2559. doi: 10.1007/s00415-024-12190-x. Epub 2024 Jan 28.
10
Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival.确定驱动肌萎缩侧索硬化症患者生存中疾病异质性的信使核糖核酸(mRNA)与微小核糖核酸(miRNA)相互作用。
Brain Commun. 2023 Dec 7;6(1):fcad331. doi: 10.1093/braincomms/fcad331. eCollection 2024.